金吾财讯 | 中国中药(00570)股价受压，午后维持低位，截至发稿，报3.93港元，跌9.03%，成交额4.46亿港元。消息面上，10月16日，中国中药发布公告披露私有化最新进程。公司私有化过程中的先决条件为境外直接投资批准和反垄断批准，先决条件最后截止日期为2024年10月18 日。公告称，由于目前预计在先决条件最后截止日期或之前不太可能获得尚未获得的境外直接投资批准，要约人和控股股东目前正在寻求投资者集团同意以延长先决条件最后截止日期，但目前仍不确定能否获得投资者集团的该等同意。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.